Use of the RETeval™ Handheld Electroretinogram Device for Assessing the Risk of Diabetic Retinopathy in Patients With Type 1 Diabetes: A Case Report
The DR score in RETeval™ electroretinogram system facilitates expeditious and uncomplicated early detection and assessment of diabetic polyneuropathy in clinical practice
Sustained Benefit of Short-Term Levodopa Treatment on Inner Retinal Function in Patients With Diabetes
Report of the 2023 Mary Tyler Moore Vision Initiative Workshop
Predicting Progression to Vision-Threatening Complications in Diabetic Retinopathy
Brief report: harmonic analysis of the 30 Hz flicker ERG in early-stage diabetic retinopathy
Advancing Toward a World Without Vision Loss From Diabetes: Insights From The Mary Tyler Moore Vision Initiative Symposium 2024 on Curing Vision Loss From Diabetes
Comparisons of oscillatory potentials and 30 Hz flicker electroretinograms for discriminating eyes with diabetic retinopathy from normal eyes
Electroretinograms Recorded with Skin Electrodes from Post-Vitrectomy Silicone Oil Filled Eyes with Proliferative Diabetic Retinopathy
Visual Function Measurements in Eyes with Diabetic Retinopathy
Electrophysiological findings in long-term type 1 diabetes patients
Early diabetic eye damage: Comparing detection methods using diagnostic power
Warning: This product can expose you to chemicals including lead, which is known to the State of California to cause cancer and birth defects or other reproductive harm. For more information go to